References
- Hughes K S, Sinion R, Songhorabodi S. Resection of the liver for colarectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278–284
- McCormack PM., Attiyeh F F. Resected pulmonary metastases lrom colorectal cancer. Dis Colon Rectum 1979; 22: 553–556
- Steele G, Ravikuma T S, Benotti P N. New surgical treatments for recurrent colorectal cancer. Cancer 1990; 65: 723–730, Suppl 3
- Abdel-Nabi H, Doerr R J. Radiolabeled monoclonal antibody-imaging (immunoscintigraphy) of colorectal cancers: Current status and future perspectives. Am J Surg 1992; 163: 448–456
- Beatty J D, Hyams D M, Morton B A. Impact of radiolabeled antibody imaging on management of colon cancer. Am J Surg 1989; 157: 13–9
- Granowska M, Jass J R, Britton K E. A prospective study of the use of 111In-labeled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Colorectal Dis 1989; 4: 97–108
- Armitage N C, Perkins A C, Pimm M V. Imaging of primary and metastatic colorectal cancer using an 111In-labeled antitumour monoclonal antibody (791T/36). Nucl Med Commun 1985; 6: 623–631
- Bischof-Delaloye A, Delaloye B, Buchegger F. Clinical value of immunoscintigraphy in colorectal carcinoma patients: A prospective study. J Nucl Med 1989; 30: 1646–1656
- Patt Y Z, Lamki L M, Shaken J. Imaging with indium-III-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 in patients with rising serum carcinoembryonic antigen levels and occult metastases. J Clin Oncol 1990; 8: 1246–1254
- Delaloye B, Bischof D A, Buchegger F. Detection of colorectal carcinoma by emission-computerized tomography after injection of 1231-labeled Fab or F(ab)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest 1986; 77: 1301–311
- Thor A, Ohuchi N, Szpak C A. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody 872.3. Cancer Res 1986; 46: 3118–3124
- Colcher D, Horan Hand P, Nuti M. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Sci USA 1981; 78: 3199–3203
- Harwood S J, Carroll R G, Webster W B. Human biodistribution of 111In-labeled B72.3 monoclonal antibody. Cancer Res 1990; 50: 932–936S
- Renda A, Salvatore M, Sava M. Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum. Preliminary report with a new monoclonal antibody: B72.3. Dis Colon Rectum 1987; 30: 683–686
- Doerr R J, Abdel-Nabi H, Krag D. Radiolabeled antibody imaging in the management of colorectal cancer. Ann Surg 1991; 214: 118–124
- Abdel-Nabi H, Doeer R J, Chan H. In-111-labeled monoclonal antibody imrnunoscintigraphy in colorectal carcinoma: Safety, sensitivity and preliminary clinical results. Radiology 1990; 175: 163–171
- Doerr R J, Abdel-Nabi H, Baker J M. Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3. Arch Surg 1990; 125: 1601–1605
- Collier B D, Abdel-Nabi H, Doerr R J. lmmunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: Comparison with CT. Radiology 1992; 185: 179–186
- Rodwell J D, Alvarez V L, Lee C. Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations. Proc Natl Acad Sci USA 1986; 83: 2632–2636